Prognostic factors for survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib

Introduction: Gastrointestinal stromal tumors are rare neoplasms of the gastrointestinal tract. A considerable number of cases have risk factors that cause early recurrence of the disease, therefore, adjuvant therapy with imatinib in this group of patients manages to increase the disease-free interv...

Full description

Saved in:
Bibliographic Details
Main Authors: Vilma Fleites-Calvo, Jorge Luis Soriano-García, Mayte Lima-Pérez, Jorge Luis Soriano-Lorenzo, Masiel González-Meisozo, Dunia Morales-Morgado, Carlos Domínguez Álvarez
Format: Article
Language:English
Published: Universidad de Ciencias Médicas de La Habana 2023-06-01
Series:Revista Habanera de Ciencias Médicas
Subjects:
Online Access:https://revhabanera.sld.cu/index.php/rhab/article/view/4983
Tags: Add Tag
No Tags, Be the first to tag this record!